Latest Breaking News On - Loretta itri - Page 1 : comparemela.com

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for.

United statesAadi bioscienceLoretta itriShihe houLauren dockeryPrnewswire aadi bioscience incAmerican society of clinical oncologyClinical oncologyAmerican societyAnnual meetingChief medical officerPoster sessionLooking statementsPrivate securities litigation reform actAnnual reportQuarterly reports

Aadi Bioscience, Inc (NASDAQ:AADI) Q1 2024 Earnings Call Transcript

Aadi Bioscience, Inc (NASDAQ:AADI) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Scott giacobelloJoe catanzaroPiper sandlerAudrey grossDave lennonAadi bioscienceLoretta itriJoseph catanzaroAadi bioscience incExchange commissionHead of corporate communications for aadi bioscienceUnidentified company representativeCall transcript mayAadi bioscience first quarterCorporate communicationsCompany representative

Aadi Bioscience (AADI) Reports Interim Results from PRECISION1 Trial of nab-Sirolimus

Aadi Bioscience (AADI) Reports Interim Results from PRECISION1 Trial of nab-Sirolimus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Loretta itriAadi bioscienceAadi bioscience incOverall response rate

Aadi Bioscience, Inc (NASDAQ:AADI) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Aadi Bioscience Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

David lennonJoe catanzaroScott giacobelloPiper sandlerMarcy grahamLoretta itriAadi bioscienceDave lennonExchange commissionAadi bioscience incFoundation medicineCorporate communicationsCall transcript novemberAadi bioscience third quarterSenior vice presidentInvestor relations

Aadi Bioscience, Inc (NASDAQ:AADI) Q2 2023 Earnings Call Transcript

Aadi Bioscience, Inc. (NASDAQ:AADI) Q2 2023 Earnings Call Transcript August 9, 2023 Aadi Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.64. Operator: Good day, and thank you for standing by. Welcome to the Aadi Bioscience, Incorporated Second Quarter 2023 Earnings Call. At this time all participants are in a […]

Loretta itriScott giacobelloMirati therapeutics